Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Therapy preferences in melanoma treatment--willingness to pay and preference of quality versus length of life of patients, physicians and healthy controls.

Authors
  • 1
  • 2
  • 1 Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. , (Germany)
  • 2 Department of Dermatology, University Hospital Erlangen, Erlangen, Germany. , (Germany)
Type
Published Article
Journal
PLoS ONE
1932-6203
Publisher
Public Library of Science
Publication Date
Volume
9
Issue
11
Identifiers
DOI: 10.1371/journal.pone.0111237
PMID: 25369124
Source
Medline
License
Unknown

Abstract

The judgment about the benefits of new treatment options largely differs between groups, physicians being the most critical against therapy. Price elasticity was low.

Statistics

Seen <100 times